Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Imaging the Immune System and Immunotherapy Response

  • You have access
    Immuno-PET imaging of the programmed cell death-1 ligand (PD-L1) using the therapeutic mAb, avelumab
    Elaine Jagoda, Falguni Basuli, Mark Williams, Ana Opina, Karen Wong, Stephen Adler, Anita Ton, Lawrence Szajek, Olga Vasalatiy, Biying Xu, Rolf Swenson and Peter Choyke
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 178;
  • You have access
    A targeted PET probe approach for non-invasive imaging of cytotoxic lymphocytes.
    Tayo Ikotun, Agnieszka Blusztajn, Christa Cortesio, Albert Gomez, Opas Nuanmanee, Brian Belmontes, Jodi Moriguchi, Gordon Moody, Pedro Beltran and Charles Glaus
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 184;
  • You have access
    Discovery and investigation of 18F labelled anti-human Adnectins to non-invasively quantify the expression of PD-L1 within tumors using Positron Emission Tomography
    David Donnelly, R. Adam Smith, Erin Cole, Wendy Hayes, Daniel Cohen, Virginie Lafont, Joonyoung Kim, Patrick Chow, Samuel Bonacorsi, Olufemi Adelakun, Xi-Tao Wang, Adrienne Pena, Jinping Gan, Martin Wright and Dasa Lipovsek
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 177;
  • You have access
    ImmunoPET of CTLA-4 expression in murine models of non-small cell lung cancer
    Emily Ehlerding, Christopher England, Hector Valdovinos, Dawei Jiang, Robert Nickles and Weibo Cai
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 181;
  • You have access
    PET imaging for assessing the differential uptake of a CD20-specific monoclonal antibody in B cell lymphoma
    Dawei Jiang, Christopher England, Emily Ehlerding, Stephen Graves, Todd Barnhart and Weibo Cai
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 180;
  • You have access
    Hematopoietic stem cell homing to bone injuries observed with Zr-89 oxine positron emission tomographic imaging.
    Kingsley Asiedu, Ferdousi Munira, Anita Ton, Stephen Adler, Peter Choyke and Noriko Sato
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 183;
  • You have access
    Targeting programmed cell death 1 receptor (PD-1) expression in lung cancer using a humanized mouse model
    Dawei Jiang, Christopher England, Emily Ehlerding, Stephen Graves, Reinier Hernandez and Weibo Cai
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 179;
  • You have access
    A novel granzyme B PET imaging peptide is predictive of immunotherapy response.
    Benjamin Larimer, Eric Wehrenberg-Klee, Frank Dubois, Anila Mehta, Taylor Kalomeris, Genevieve Boland, Keith Flaherty and Umar Mahmood
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 182;
  • You have access
    Direct Cell Labelling with 89Zr(oxine)4 allows In Vivo PET Imaging of Gamma-delta T-cells in a Breast Cancer Model
    Francis Man, Lindsay Lim, Hilary Shmeeda, Alberto Gabizon, Philip Blower, Gilbert Fruhwirth and Rafael T.M. de Rosales
    Journal of Nuclear Medicine May 1, 2017, 58 (supplement 1) 185;
SNMMI

© 2025 SNMMI

Powered by HighWire